APG Asset Management
NVAX icon

APG Asset Management’s Novavax NVAX Stock Holding History

APG Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,200
Closed -$212K – 927
2022
Q1 		$212K Sell
3,200
-5,000
-61% -$446K ﹤0.01% 895
2021
Q4 		$1.03M Buy
8,200
+3,200
+64% +$550K ﹤0.01% 716
2021
Q3 		$894K Sell
5,000
-1,500
-23% -$331K ﹤0.01% 774
2021
Q2 		$1.16M Buy
+6,500
New +$1.19M ﹤0.01% 763

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

APG Asset Management's NVAX Position: Q2 2022 in Review

APG Asset Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 3,200 shares — an estimated $212K sold.

APG Asset Management first reported a position in NVAX in Q2 2021 and held it in 4 quarters. The position peaked at $1.16M in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • APG Asset Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • APG Asset Management sold 3,200 Novavax shares in Q2 2022, an estimated $212K.
  • APG Asset Management first reported a position in Novavax in Q2 2021 and held it in 4 quarters.
  • APG Asset Management's Novavax position peaked at $1.16M in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on APG Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.